Ground-breaking New Scientific Publication on anti-Abeta Vaccine in Preclinical Model of Down Syndrome

Categories: Blog, Clinical Trials, Ds Research, News
By Dr. Michael Harpold, LuMind RDS Chief Scientific Officer AC Immune announced the publication of a ground-breaking scientific study on an anti-A-beta vaccine potentially signaling a way to treat cognitive deficits in people with Down syndrome (Ds). The study, entitled An anti-Abeta-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome, was …

Read More